Decoding Biologics Tech Transfer: Guiding Process Performance Across Sites, Scales, and Bioreactor Systems
Successful biologics tech transfer depends on understanding what changes when a process moves to a new facility, production scale, or bioreactor platform. Identifying those differences early can help teams make better technical decisions while reducing risk as programs advance toward cGMP manufacturing.
This webinar explores strategies for transferring and scaling upstream biologics processes, from initial gap assessments and facility-fit evaluations to detailed process science and bioreactor modeling. Learn how critical scale-dependent parameters, including kLa and mixing time, inform transfer strategies and why challenges such as CO₂ removal become increasingly important at larger scales.
The session also considers transfers between CDMOs, progression from cell line development to cGMP production, and dual-site manufacturing approaches designed to provide greater manufacturing flexibility. Real-world examples illustrate how technical knowledge and established manufacturing experience can guide process performance across changing production environments
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.